NeoStem, Inc. Announces 2014 Year-End Financial Results And Provides Corporate Update

NeoStem, Inc. , a biopharmaceutical company developing novel, cell-based personalized medicine therapies, announced today 2014 year end results and provided an update on its business. "We are pleased with our company's achievements in 2014 and look forward to reporting on our progress advancing the programs in our diversified and balanced pipeline," said Dr. David J. Mazzo, Chief Executive Officer of NeoStem.

http://ift.tt/1zF51MU